Inoue, Kenji
Shiokawa, Minako
Kunimatsu-Sanuki, Shiho
Kang, Jungshin
Uraki, Takehiko
Tomita, Goji
Ishida, Kyoko
Article History
Received: 13 October 2023
Accepted: 31 January 2024
First Online: 8 April 2024
Declarations
:
: K. Inoue, Grants or contracts (Otsuka, Wakamoto), Lecture fee (Senju, Otsuka, Kowa, Santen, Allergan, Novartis, HOYA, Pfizer, Viatris, Rohto Nitten); M. Shiokawa, Lecture fee (Otsuka); S. K-Sanuki, Lecture fee (Santen, Otsuka, Kowa, Nitto Medic, Novartis); J. Kang, None; T. Uraki, None; G. Tomita, Grants or contracts (Pfizer, Santen, Senju, Eisai, Handaya, Kowa, Otsuka), Lecture fee (Santen, Senju, Allergan, TOPCON); K. Ishida, Lecture fee (Alcon, Pfizer, Santen, Senju, Otsuka, Kowa, Sucampo, GSK, JFC Sales Plan, Novartis, Wakamoto, Allergan, Bayer, Nitto Medic).